Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Amortizatization of Intangibles (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $228000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 117.23% year-over-year to $228000.0, compared with a TTM value of $889000.0 through Dec 2025, up 6.85%, and an annual FY2025 reading of $889000.0, up 6.85% over the prior year.
  • Amortizatization of Intangibles was $228000.0 for Q4 2025 at aTYR PHARMA, up from -$320000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $977000.0 in Q3 2023 and bottomed at -$1.3 million in Q4 2024.
  • Average Amortizatization of Intangibles over 5 years is $148550.0, with a median of $220000.0 recorded in 2022.
  • The sharpest move saw Amortizatization of Intangibles skyrocketed 295.52% in 2023, then tumbled 925.58% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$983000.0 in 2021, then skyrocketed by 103.26% to $32000.0 in 2022, then tumbled by 503.12% to -$129000.0 in 2023, then crashed by 925.58% to -$1.3 million in 2024, then surged by 117.23% to $228000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ATYR at $228000.0 in Q4 2025, -$320000.0 in Q3 2025, and $765000.0 in Q2 2025.